- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01987778
Health Effects of Resistance Training on Postmenopausal Women
Today's women will live more than a third of their lives after menopause, i.e. with a changed hormonal and metabolic state. Vasomotor symptoms like hot flushes and sweating are reported by about 75% of all women around menopause and may impair well-being, mental state, daily activities and night sleep. Vasomotor symptoms are less prevalent in women who participate in regular physical exercise. It is, however, still uncertain if physical exercise reduces vasomotor symptoms.
The purpose of this randomized controlled study is to establish possible beneficial health effects from 15 weeks of supervised resistance training (RT) on postmenopausal women. End-points include effects from RT in postmenopausal women on
- clinical outcomes (number and severity of vasomotor symptoms, Health-Related quality of Life (HRQoL), Body Mass Index (BMI), abdominal height, muscle strength and mass, browning of fat),
- diagnostic variables (production of myokines as irisin, immunological markers) and
- genetic variables (length of telomeres).
The control group will be offered resistance training after the intervention period.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Linköping, Sweden, 58185
- County Council of Östergötland, Kvinnokliniken
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Postmenopausal women who had at least 28 moderate to severe hot flashes per week during a screening period of two weeks.(Postmenopausal, i.e. had their last menstrual bleeding at least 12 months ago or have increased gonadotrophic hormones showing they are postmenopausal.)
- At lest 45 years of age
- Good physical health and physical ability to take part in organized resistance training or other training at least three times per week.
- Ability to speak and read Swedish
- Freely informed consent for participation
Exclusion Criteria:
- Physically active more than 75 minutes of intense exercise per week or more than 150 minutes of low intensity activities
- Hb <110 g/l
- Blood pressure >160 systolic and/or >100 mmHg diastolic pressure
- Ongoing usage or use during the last two months of hormone therapy aimed for hot flashes
- Treatment with psychopharmacological drugs (e.g SSRI or SNRI) or other treatment with a possible effect on menopausal symptoms
- Uninvestigated or unstable disease that could affect presence of flushes (e.g thyroid disease)
- Other medical condition that is judged inappropriate to combine with physical activity or participation in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Resistance training
The resistance training will be supervised and individualized by an experienced physiotherapist.
First the relative load will be lighter during three weeks, thereafter the intensity and load will be increased over another 12 weeks.
|
Resistance training supervised and individualized by an experienced physiotherapist.
First the relative load will be lighter during three weeks, thereafter the intensity and load will be increased over another 12 weeks.
|
NO_INTERVENTION: Control group
No intervention for 15 weeks but the same registrations, diaries and forms as the intervention group.
The control group will however be omitted from muscle strength testing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in frequency of hot flushes per 24 h
Time Frame: Baseline to 15 weeks of intervention/control group
|
Frequency of hot flushes per 24 h daily recorded in hot flush diary from baseline throughout 15 weeks of intervention.
Comparison between intervention group and control group.
|
Baseline to 15 weeks of intervention/control group
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-related quality of life (HRQoL)
Time Frame: Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
HRQoL will be measured with a generic measure (Short Form Health Survey - SF-36) and a measure specifically developed for mid-aged women (Women's Health Questionnaire)
|
Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
Muscle strength
Time Frame: Baseline to 15 weeks of intervention
|
Muscle strength will be evaluated in the intervention group with 8 repetition maximum (8 RM) tests for the major muscles in the extremities.
|
Baseline to 15 weeks of intervention
|
Level of physical activity
Time Frame: Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
Physical activity will be evaluated using diary and the International Physical Activity Questionnaire (IPAQ).
|
Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
Concentrations of adipo-myokines/inflammatory biomarkers
Time Frame: Baseline to 15 weeks of intervention/control group
|
The markers to assess are as follows: Leptin, Irisin, IL-6, IL-7, IL-8, monocyte chemoattractant protein-1(MCP-1), tumor necrosis factor (TNF), IL-4, IL-10, IL-15, brain-derived neurotrophic factor (BDNF), matrix metalloproteinase (MMP)-2 and MMP-9 in blood samples shortly after a resistance-training and on a day without work-out; samples with direct measurement (plasma) and after white blood cell stimulation, conditioned medium with multiple bead technology (Luminex) and enzyme linked immunosorbent assay (ELISA)
|
Baseline to 15 weeks of intervention/control group
|
Length of telomeres
Time Frame: Baseline to 15 weeks of intervention/control group
|
Length of telomeres will be measured in DNA isolated from blood samples with a qPCR based method.
Recently, the telomere length was associated with certain SNP´s in the hTERT gene and these will also be assessed.
|
Baseline to 15 weeks of intervention/control group
|
Volume of white and brown adipose tissue and muscle volume
Time Frame: Baseline to 15 weeks of intervention/control group
|
Using magnetic resonance imaging (MRI) the volume of total (TAT), subcutaneous (SCAT) and visceral (VAT) white adipose tissue (Dahlqvist Leinhard 2008); the concentration of lipids diffusively stored in the liver parenchyma, and the volume of intramuscular adipose tissue (IMAT) in the quadriceps muscle will be quantified.
Furthermore, the MRI images will be used to quantify the volume of and fat concentration in supraclavicular and interscapular brown adipose tissue according to our recently published measurement protocol (Lidell 2013, Borga 2013), as well as the volume of the major extensor and flexor muscles (Karlsson 2013).
|
Baseline to 15 weeks of intervention/control group
|
Body mass index and abdominal height
Time Frame: Baseline to 15 weeks of intervention/control group
|
Weight and length (BMI) and abdominal height measured with an abdometer
|
Baseline to 15 weeks of intervention/control group
|
Blood pressure
Time Frame: Baseline to 15 weeks of intervention/control group
|
Using standard measure technique for blood preassure
|
Baseline to 15 weeks of intervention/control group
|
Severity of hot flushes
Time Frame: Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
Severity of hot flushes per 24 h recorded in hot flush diary from baseline throughout 15 weeks of intervention and one week during follow-up at 6 and 24 months.
|
Baseline to 15 weeks of intervention/control group. Follow-up after 6 and 24 months.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mats L Hammar, Professor, Linkoeping University
Publications and helpful links
General Publications
- Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.
- Dahlqvist Leinhard O, Johansson A, Rydell J, Smedby Ö, Nyström F, Lundberg P, Borga M. Quantitative Abdominal Fat Estimation Using MRI. 2008 19th International Conference on Pattern Recognition, ICPR 2008 , art. no. 4761764.
- Lidell ME, Betz MJ, Dahlqvist Leinhard O, Heglind M, Elander L, Slawik M, Mussack T, Nilsson D, Romu T, Nuutila P, Virtanen KA, Beuschlein F, Persson A, Borga M, Enerback S. Evidence for two types of brown adipose tissue in humans. Nat Med. 2013 May;19(5):631-4. doi: 10.1038/nm.3017. Epub 2013 Apr 21.
- Borga M, Virtanen KA, Romu T, Leinhard OD, Persson A, Nuutila P, Enerback S. Brown adipose tissue in humans: detection and functional analysis using PET (positron emission tomography), MRI (magnetic resonance imaging), and DECT (dual energy computed tomography). Methods Enzymol. 2014;537:141-59. doi: 10.1016/B978-0-12-411619-1.00008-2.
- Karlsson A, Rosander J, Tallberg J, Romu T, Borga M, Dahlqvist Leinhard O. Whole Body Muscle Classification using Multiple Prototype Voting. Proceedings of the ISMRM Annual Meeting (ISMRM'13), 2013.
- Daley A, Stokes-Lampard H, Macarthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2011 May 11;(5):CD006108. doi: 10.1002/14651858.CD006108.pub3.
- Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010 Jun 3;411(11-12):785-93. doi: 10.1016/j.cca.2010.02.069. Epub 2010 Feb 25.
- Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas. 1998 Jun 3;29(2):139-46. doi: 10.1016/s0378-5122(98)00004-8.
- Kim JH, Ko JH, Lee DC, Lim I, Bang H. Habitual physical exercise has beneficial effects on telomere length in postmenopausal women. Menopause. 2012 Oct;19(10):1109-15. doi: 10.1097/gme.0b013e3182503e97.
- Lindh-Astrand L, Nedstrand E, Wyon Y, Hammar M. Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy. Maturitas. 2004 Jun 15;48(2):97-105. doi: 10.1016/S0378-5122(03)00187-7.
- Taylor JD, Fletcher JP. Reliability of the 8-repetition maximum test in men and women. J Sci Med Sport. 2012 Jan;15(1):69-73. doi: 10.1016/j.jsams.2011.07.002. Epub 2011 Aug 5.
- Berin E, Spetz Holm AC, Hammar M, Lindh-Astrand L, Bertero C. Postmenopausal women's experiences of a resistance training intervention against vasomotor symptoms: a qualitative study. BMC Womens Health. 2022 Jul 30;22(1):320. doi: 10.1186/s12905-022-01900-0.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20131105/Styrka
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hot Flashes
-
Mitsubishi Tanabe Pharma America Inc.CompletedMenopause Hot FlashesUnited States
-
University of California, San FranciscoCompleted
-
University of California, San FranciscoCompleted
-
AmgenCompleted
-
Alison Huang, MDNational Institute on Aging (NIA)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedTreatment of Menopausal Hot FlashesUnited States
-
Donesta BioscienceSynteractHCRCompleted
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)CompletedHot Flashes | Hot FlushesUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedFever, Sweats, and Hot FlashesUnited States
-
University of PennsylvaniaForest LaboratoriesCompleted
Clinical Trials on Resistance training
-
University of KasselCompleted
-
University of KasselUniversity of PotsdamCompleted
-
University of Alabama at BirminghamCompletedMusculoskeletal and Metabolic CrosstalkUnited States
-
University of Applied Sciences of Western SwitzerlandCompleted
-
University of BarcelonaCompleted
-
Vienna Hospital AssociationRecruiting
-
Universidade Federal do Triangulo MineiroUnknown
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Hong Kong Metropolitan UniversityRecruitingFrailty | Mood | Cognition | Mobility | SacropeniaHong Kong
-
Riphah International UniversityCompletedSports Physical Therapy | Anthropometric Measurements and Elastic Resistance TrainingPakistan